Search research articles
Contact Us
Filters
Showing results (71-80 of 172) with videos related to
Page
of 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2022
A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma
Martin H Voss, Arun A Azad, Aaron R Hansen, et al.
Cancer Medicine
|
October 11, 2023
Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS-001 clinical trial
Alberto Hernando-Calvo, Eoghan Malone, Daphne Day, et al.
The Canadian Journal of Urology
|
August 11, 2021
The financial impact of cancer care on renal cancer patients
Doreen A Ezeife, Brendon Josh Morganstein, Steven Yip, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 2022
Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study
Caroline Even, Jean-Pierre Delord, Katharine A Price, et al.
Current Oncology (Toronto, Ont.)
|
February 24, 2021
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer
Domen Ribnikar, Igor Stukalin, Philippe L Bedard, et al.
European Urology
|
August 17, 2016
Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular Cancer
Madhur Nayan, Michael A S Jewett, Ali Hosni, et al.
The Oncologist
|
January 20, 2025
A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer
Emiliano Calvo, Bernard Doger, Joan Carles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 25, 2017
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
Chiun Hsu, Se-Hoon Lee, Samuel Ejadi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2022
Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study
David M O'Malley, Giovanni Mendonca Bariani, Philippe A Cassier, et al.
British Journal of Cancer
|
May 21, 2019
A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial
Grainne M O'Kane, Shereen Ezzat, Anthony M Joshua, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 172) with videos related to
Sort By:
Page
of 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2022
A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma
Martin H Voss, Arun A Azad, Aaron R Hansen, et al.
Cancer Medicine
|
October 11, 2023
Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS-001 clinical trial
Alberto Hernando-Calvo, Eoghan Malone, Daphne Day, et al.
The Canadian Journal of Urology
|
August 11, 2021
The financial impact of cancer care on renal cancer patients
Doreen A Ezeife, Brendon Josh Morganstein, Steven Yip, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 2022
Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study
Caroline Even, Jean-Pierre Delord, Katharine A Price, et al.
Current Oncology (Toronto, Ont.)
|
February 24, 2021
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer
Domen Ribnikar, Igor Stukalin, Philippe L Bedard, et al.
European Urology
|
August 17, 2016
Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular Cancer
Madhur Nayan, Michael A S Jewett, Ali Hosni, et al.
The Oncologist
|
January 20, 2025
A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer
Emiliano Calvo, Bernard Doger, Joan Carles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 25, 2017
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
Chiun Hsu, Se-Hoon Lee, Samuel Ejadi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2022
Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study
David M O'Malley, Giovanni Mendonca Bariani, Philippe A Cassier, et al.
British Journal of Cancer
|
May 21, 2019
A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial
Grainne M O'Kane, Shereen Ezzat, Anthony M Joshua, et al.
Page
of 18